7 completed, 1 unknown, 1 withdrawn. 9 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 7, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Stage III Cervical Cancer: new trials by email Literature Review of Stage III Cervical Cancer trials Research Report on Stage III Cervical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer Nimotuzumab, Cisplatin, external-beam radiation - Neoplasms, Cervical Adenosquamous Cell Carcinoma | Phase 2 | Unknown | Zhujiang Hospital | 100 | 2018-03-20 | 2018-08-13 |
| Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer External Beam Radiation Therapy, PDR Brachytherapy, Cisplatin - Cervical Adenocarcinoma, Stage IB Cervical Cancer | Phase 2 | Completed | Institut de Cancérologie de Lorraine | 48 | 2011-06-06 | 2026-09-01 |
| Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer Filgrastim, Laboratory Biomarker Analysis, Pegfilgrastim - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 27 | 2011-02-01 | 2019-08-08 |
| Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes proton beam radiation therapy, radiation therapy treatment planning/simulation, cisplatin - Cervical Cancer, Stage IB Cervical Cancer | Phase 2 | Withdrawn | Abramson Cancer Center at Penn Medicine | 2009-07-01 | 2020-04-03 | |
| Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer triapine, cisplatin, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Vaginal Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 26 | 2009-07-01 | 2017-11-17 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 50 | 2009-05-01 | 2013-11-28 |
| FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer 18F-fluoromisonidazole, fluorodeoxyglucose F 18, positron emission tomography - Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 16 | 2007-11-01 | 2016-12-30 |
| Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer fludeoxyglucose F 18, positron emission tomography, computed tomography - Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 384 | 2007-09-01 | 2019-07-23 |
| EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer EF5 - Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 60 | 2005-02-01 | 2013-01-16 |
Uterine Cervical Neoplasms (9) · Endometrial Neoplasms (3) · Carcinoma, Ovarian Epithelial (2) · Vaginal Neoplasms (2) · Fallopian Tube Neoplasms (1) · Neoplasms (1) · Uterine Cervical Dysplasia (1) · Vulvar Neoplasms (1)
Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Genital Diseases (9) · Genital Diseases, Female (9) · Genital Neoplasms, Female (9) · Neoplasms by Site (9) · Urogenital Diseases (9) · Urogenital Neoplasms (9) · Uterine Cervical Diseases (9) · Uterine Diseases (9) · Uterine Neoplasms (9) · Neoplasms (8) · Adnexal Diseases (2) · Carcinoma (2) · Endocrine Gland Neoplasms (2)
Cisplatin (4) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (3) · Fluorodeoxyglucose F18 (3) · Magnetic Resonance Spectroscopy (3) · 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1) · Brachytherapy (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Proton Therapy (1) · Radiosurgery (1) · Sentinel Lymph Node Biopsy (1) · Topotecan (1) · ferumoxtran-10 (1) · fluoromisonidazole (1) · nimotuzumab (1)
National Cancer Institute (NCI) (5) · Abramson Cancer Center at Penn Medicine (1) · Case Comprehensive Cancer Center (1) · Institut de Cancérologie de Lorraine (1) · Zhujiang Hospital (1)
United States (6) · Canada (1) · China (1) · France (1) · Japan (1) · South Korea (1)
Charles Kunos (2) · Christina Chu (1) · Joseph Rajendran (1) · Lillie Lin (1) · Mostafa Atri (1) · Robert DeBernardo, MD (1)
U10CA027469 (2), U10CA180868 (2), N01CM37008 (1), P30CA043703 (1), R21CA099346 (1), U01CA062502 (1)